Peter Tygesen

Peter Tygesen has a diverse work experience spanning over several companies. Peter is currently the Managing Director of Vaccine Adjuvants at Croda where they are responsible for creating and selling specialty chemicals used in various industries. Previously, they served as the CEO of Brenntag Biosector, a leading developer and manufacturer of adjuvants for vaccines. Prior to that, they were the Managing Director of Riemann A/S, a Danish dermo-cosmetic company, where they successfully implemented a new strategic direction and achieved significant growth. Peter has also held leadership positions at EGALET LIMITED, Astion Pharma A/S, and Lundbeck, where they demonstrated their expertise in pharmaceutical R&D, production, and development. In their various roles, they have successfully led teams, executed research and development projects, and achieved significant efficiency improvements.

Peter Tygesen earned a Bachelor's Degree in Sports Studies from Syddansk Universitet - University of Southern Denmark, which they completed from 1984 to 1986. Peter then pursued a Master's Degree in Organic Chemistry from the same university, completing it from 1986 to 1992.